2022-2029 年全球疫苗恆溫箱市場

市場概覽

在預測期內（2022-2029 年），全球疫苗恆溫箱市場規模預計將以 7.0% 的複合年增長率增長。

疫苗在運輸過程中使用冷藏箱和小型抗體轉運蛋白保持低溫。 等溫箱是冷箱和免疫載體的超集。 免疫轉運蛋白與冷藏箱具有相似的特性，只是它們的體積較小。

疫苗恆溫箱市場可以根據材料細分為聚氨酯、聚丙烯、聚乙烯、聚苯乙烯等。 一種用途廣泛的材料類型是聚氨酯。 聚氨酯泡沫是通過多元醇和二異氰酸酯反應生產的。 等溫填料是在高密度聚氨酯泡沫上形成兩層氧化鋁，並用足夠的力將它們粘合在一起，以達到優異的硬度。

另外，在疫苗領域，有遠距離和近距離等溫箱。 遠距離等溫疫苗容器有兩種尺寸：5-15 升和 15-25 升。 疫苗領域的短程等溫箱分為15和25升、5和15升、5升以下。

市場動態

對到達疫苗最後一英裡的經濟型冷鏈解決方案的需求不斷增長，這推動了恆溫器的發展。

對能夠實現疫苗最後一英裡交付的經濟型冷鏈解決方案的需求不斷增長，這推動了恆溫容器的發展。

疫苗是全球健康和發展領域最重要的成就之一。 兩個多世紀以來，疫苗成功地減少了小兒麻痺症、麻疹和天花等疾病的肆虐，讓孩子們健康快樂地成長。 據聯合國兒童基金會稱，甚至在 COVID-19 到來之前，它每分鐘就挽救了 5 條以上的生命，每年避免 300 萬人死亡。

全球免疫工作使兒童能夠行走、玩耍和學習。 接種疫苗的兒童在學校表現更好，從而為他們的社區帶來經濟利益。 疫苗現在被認為是改善全球福利的最具成本效益的方法之一。

但是，最後一英裡的疫苗供應不足和不合格是對公眾健康的最大威脅之一。 據聯合國兒童基金會稱，每年約有 2000 萬兒童無法獲得拯救生命的疫苗。 在許多情況下，需要疫苗的最貧困和最邊緣化的兒童獲得疫苗的可能性最小。 聯合國兒童基金會及其合作夥伴正在使用太陽能、移動技術和遙測技術來確保每個孩子都接種了疫苗，而不是因為極端的高溫或寒冷而變得無效。。

裝有疫苗（尤其是抗體轉運蛋白）□□的恆溫箱足夠小，一個健康專家可以通過車輛或步行將其運送到工作地點。 此外，等溫抗體還可以將疫苗接種從基本醫療場所轉移到過渡性疫苗接種商店。

庫存網絡管理不當制約疫苗恆溫箱市場

全球疫苗恆溫箱市場預計將受到供應鏈管理不善的阻礙。 冷卻液包使用不當和恆溫器選擇錯誤都是管理不善的例子。 諸多困難阻礙了冷鏈物流管理。

儘管需求量很大，但很少有物流供應商能夠應對交付高度管制的藥品（例如等溫疫苗）的挑戰。 例如，在美國，78% 的冷藏倉庫已超過 20 年，已經過時，無法滿足現代運營需求。

車輛管理效率低下也是必須解決的問題之一。 冰箱和車輛經常出故障。 訂購額外的零件和執行日常維護會減慢操作速度。 同時，由於冷鏈無法跟蹤車輛移動，裝運可能會延遲，進口貨物可能會在入境口岸等待很長時間。

此外，運輸需要精確溫度和濕度條件的原材料成本很高。 然而，在可見性和管理有限的情況下，即使是運輸環境的微小變化也可能導致巨大的損失。 特別是當涉及到昂貴的藥物時，風險更大。

如果供應鏈沒有保持在適當的溫度範圍內，疫苗接種的有效性可能會受到影響，尤其是對於昂貴的藥物。 目前正在努力將等溫包裝商業化以防止結冰。

COVID-19 影響分析

COVID-19 大流行帶來的全球健康危機推動了對用於對抗 SARS-CoV-2 病毒的恆溫疫苗運輸箱的需求。 所有熱敏疫苗都使用主動或被動冷製造方法控制儲存溫度範圍，但早期的 COVID-19 疫苗需要在 -90 至 -60°C 之間儲存和運輸。我有。

傳統的 -25/-15°C 範圍內的共晶板無法滿足此溫度要求，因為它們的熔點不接近 -70°C。 乾冰在 78.5°C 時的昇華焓為 573 kJ.kg-1 (25,2 kJ.mol-1)，是保持這些疫苗接種低溫的最佳方法。

在運輸疫苗等對熱敏感的保健食品時，我們提供裝有冰袋的保溫箱，以補償與外界的熱交換。

市場驅動力可能是需要溫控冷藏托運人在全球範圍內運輸高質量的 COVID-19 疫苗。 例如，輝瑞注射劑需要在-70°C下長期儲存，而Moderna注射劑需要在-20°C下長期儲存。

COVID-19 疫苗接種是幫助遏制 COVID-19 大流行的重要預防措施。 隨著疫苗接種活動的普及和疫苗生產效率的提高，預計對恆溫箱的需求將會增加。 行業進入者正在鞏固其在全球恆溫疫苗盒市場的地位。

內容

第 1 章全球疫苗恆溫箱市場研究方法和範圍

• 調查方法
• 調查目的和範圍

第 2 章全球疫苗恆溫箱市場 - 市場定義和概述

第 3 章全球疫苗恆溫器市場-執行摘要

• 按產品細分的市場
• 按材料細分的市場
• 按地區劃分的市場細分

第 4 章全球疫苗恆溫器市場 - 市場動態

• 市場影響因素
  • 司機
    • 為到達疫苗的最後一英裡，對經濟型冷鏈解決方案的需求不斷增長，這推動了恆溫箱的發展
  • 約束因素
    • 不完善的庫存管理系統抑制了疫苗恆溫槽的市場
  • 商機
  • 影響分析

第五章全球疫苗恆溫箱市場-行業分析

• 波特的五力分析
• 供應鏈分析
• 定價分析
• 監管分析

第 6 章全球疫苗恆溫器市場 - COVID-19 分析

• COVID-19 市場分析
  • COVID-19 之前的市場情景
  • COVID-19 的當前市場情景
  • COVID-19 後或未來情景
• COVID-19 期間的價格動態
• 供需範圍
• 大流行期間與市場相關的政府舉措
• 製造商的戰略舉措
• 總結

第 7 章全球疫苗恆溫器市場 - 按產品分類

• 近程
  <5 升
  • 5-15 升
  • 15-25 升
• 遠程
  • 5-15 升
  • 15-25 升

第 8 章全球疫苗恆溫器市場 - 按材料分類

• 聚氨酯
• 聚丙烯
• 聚乙烯
• 聚苯乙烯
• 其他

第 9 章按地區分列的全球疫苗恆溫器市場

• 北美
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲
  • 德國
  • 英國
  • 法國
  • 意大利
  • 西班牙
  • 其他歐洲
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 中東和非洲

第 10 章等溫疫苗容器的全球市場 - 競爭格局

• 競爭場景
• 市場分析/份額分析
• 併購分析

第 11 章全球疫苗恆溫器市場-公司概況

• B Medical Systems
  • 公司概況
  • 最終用戶的產品組合和描述
  • 主要亮點
  • 財務摘要
• BLOWKINGS India
• Sonoco ThermoSafe
• Termo-Kont MK LLC
• AOV International LLP
• Apex International
• PHC Holdings Corporation
• Tempack
• Tecnisample SL
• Nilkamal Material Handling

第12章 重要考察

第13章 DataM

Market Overview

The global isothermal boxes for vaccine market size was worth US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 7.0% within the forecast period (2022-2029).

Immunizations are kept chilled during shipment using cold boxes and miniature antibody transporters. Isothermal boxes are the superset of cold boxes and vaccination carriers. Immunization transporters offer similar properties as cold boxes, except they have a smaller volume.

Based on the material, isothermal boxes for the vaccine market can be classified as polyurethane, polypropylene, polyethylene, polystyrene and others. A material type that has many different applications is polyurethane. Polyols and diisocyanates react to produce polyurethane foam. High-density polyurethane foam with two aluminized layers molded and linked with enough force to provide outstanding hardness makes up isothermal packing.

For the vaccination sector, there are also long-range and short-range isothermal boxes. The two sizes of long-range isothermal vaccine containers are 5-15 liters and 15-25 liters. Short-range isothermal boxes in the vaccine sector are divided into 15 and 25 liters, 5 and 15 liters and under 5 liters.

Market Dynamics

Improving demand for economical cold chain solutions for the last-mile reach of vaccines is boosting the isothermal boxes.

Improving demand for economical cold chain solutions for the last-mile reach of vaccines is boosting the isothermal boxes

Vaccines are one of the most significant successes in world health and development. Vaccines have successfully decreased the scourge of diseases like polio, measles and smallpox for over two centuries, allowing children to grow healthy and happy. According to UNICEF, even before COVID-19 arrived, they saved more than five lives every minute, averting up to three million fatalities yearly.

Children can walk, play and learn thanks to global immunization initiatives. Vaccinated children perform better in school, resulting in economic benefits for their communities. Vaccines are now considered one of the most cost-effective ways to improve global welfare.

However, improper and incompetent vaccine supply for the last-mile reach is one of the top threats to public health. According to UNICEF, some 20 million children miss out on life-saving vaccines annually. The poorest and most marginalized children who often need vaccines are the least likely to get them. Therefore, UNICEF and their partners harness solar power, mobile technology and telemetrics to assure vaccines reach all children without losing their effectiveness from vulnerability to extreme heat or cold weather conditions.

A solitary well-being specialist can convey isothermal boxes for the vaccine, particularly antibody transporters, via vehicle or walking to an effort meeting because of their small size. Moreover, isothermal antibodies also move immunizations from essential medical care habitats to transitional immunization stores.

Poor administration of the inventory network is restraining the isothermal boxes for the vaccine market

The global isothermal boxes for vaccines market is projected to be hampered by poor supply chain management. The improper use of coolant packs and the selection of inappropriate isothermal boxes, among other things, are examples of poor management. A slew of difficulties is hampering cold chain logistics management.

Despite the great demand, only a few logistics businesses can meet the difficulty of delivering isothermal vaccination and other highly regulated pharmaceutical products. In U.S., for example, 78 percent of cold storage warehouses are over two decades old and unfit for modern operational needs.

Inefficiencies in fleet management are another issue that must be addressed. Refrigerators and vehicles frequently fail. Ordering extra parts and performing routine maintenance might slow down operations. At the same time, a lack of cold chain insight into fleet movements can cause shipping delays and instances where imported products wait at ports of entry for an extended period.

Furthermore, transporting materials that require exact temperature and humidity conditions is costly. However, with limited sight and control, even little changes in the transportation environment might result in significant losses. The stakes are particularly higher when it comes to high-value pharmaceuticals.

As a result, vaccinations will likely lose efficacy if the supply chain is not kept within the proper temperature range. Significant efforts are being made to bring freeze-safe isothermal vaccination packaging to market.

COVID-19 Impact Analysis

The worldwide health crisis brought on by the COVID-19 pandemic has boosted demand for isothermal vaccine transport boxes to combat the SARS-CoV-2 virus. All heat-sensitive vaccines have storage temperature ranges controlled using active or passive cold manufacturing methods, but the earliest COVID-19 vaccines must be stored and transported between -90 and -60 °C.

Traditional eutectic plates for the -25/-15 °C range cannot meet the temperature requirement since they do not have melting temperatures near -70 °C. With a sublimation enthalpy of 573 kJ.kg-1 (25,2 kJ.mol-1) at -78.5 °C, dry ice is the best approach to keep these vaccinations cold.

Insulated boxes are supplied with a cold source to compensate for thermal exchanges with the outside when transporting vaccinations and other heat-sensitive health items.

The market is likely driven by the requirement for temperature-controlled thermal shippers to transfer high-quality COVID-19 vaccines globally. For example, the Pfizer jab requires long-term storage at -70°C, but the Moderna jab requires long-term storage at -20°C.

COVID-19 immunization is an important preventative step that can assist in bringing the COVID-19 pandemic to a stop. The need for isothermal boxes is predicted to rise as vaccination campaigns become widespread and vaccine manufacturing becomes more efficient. The industry's participants are strengthening their position in the worldwide isothermal vaccine boxes market.

Segment Analysis

The global isothermal boxes for vaccine market is segmented by product, material and region.

Long range vaccine boxes are portable with reduced capacity for a longer travel time range of 24 hours to 8 days

Based on product, the global isothermal boxes for vaccine market is segmented into short range and long range. The long range holds a major share in isothermal boxes for the vaccine market. Vaccines are kept chilled throughout shipment using cold boxes and miniature vaccine carriers. Isothermal boxes are defined as the superset of cold boxes and vaccine carriers. Vaccine carriers are similar to cold boxes, except that they have a lower volume. Because both cold boxes and vaccine carriers are passive carriers, coolant packs that offer warmth for a set amount of time are required.

Vaccine carriers are portable due to their reduced capacity. They're used to deliver vaccinations and diluents from hospitals to rural locations where ice and refrigeration aren't available.

Depending on their use, cold boxes can last from a few hours to many days. Vaccines are not time-limited, but they must be kept between 2 and 8 degrees Celsius from the time they are created until they are administered.

In comparison to any other type of vaccine packaging, the isothermal container constructed of expanded polyethylene and polypropylene is in high demand. It provides good thermal insulation. Vacuum Insulation Panels, dry ice or PCM-filled cooling plates can keep the temperature steady for hours or days.

Geographical Analysis

Asia-Pacific market is expected to expand at a higher rate than the rest of the regions due to the increasing number of small and unorganized packaging manufacturers in emerging countries such as China, India, Indonesia and others

The Asia-Pacific market is expected to expand at a higher rate than the rest of the regions due to the increasing number of small and unorganized packaging manufacturers in emerging countries such as China, India, Indonesia and others.

Furthermore, due to rising vaccination awareness and increased immunization programs, Asia-Pacific presents lucrative prospects for isothermal boxes key vaccine industry players to grow in the forecast period. The market expansion in this region may be attributed to an increase in vaccination demand, senior population, awareness and continued government support for vaccine development.

All countries and territories in Asia-Pacific have established vaccination programs that include a minimum number of routine vaccines (such as those for polio, diphtheria, tetanus, pertussis and measles); additional vaccines (such as those for pneumococcus, rotavirus and human papillomavirus) are added at the national or subnational level based on local morbidity, mortality and cost-effectiveness analysis.

In addition, In 2019, the overall vaccination of children against pertussis (provided through combined vaccines containing diphtheria and tetanus), measles and hepatitis B was high in most Asia-Pacific countries. While vaccination rates have plateaued at a high level in many countries and territories in Asia-Pacific, some countries with historically low rates have made substantial progress in recent years.

Vaccine safety surveillance is improving globally, with 73% and 63% of nations reporting adverse events following immunization in the WHO areas of South East Asia and the Western Pacific, respectively. Thus improving vaccination percentage in the region has created a huge market share for isothermal boxes for vaccine storage in the Asia-Pacific region.

Competitive Landscape

The global isothermal boxes for vaccine market is highly competitive with local and global key players. The key players contributing to the market's growth are B Medical Systems, BLOWKINGS India, Sonoco ThermoSafe, Termo-Kont MK LLC, AOV International LLP, Apex International, PHC Holdings Corporation, Tempack, Tecnisample SL, Nilkamal Material Handling, Isonova among others.

The major companies are adopting several growth strategies, such as product launches, acquisitions and collaborations, contributing to the global growth of the isothermal boxes for vaccine market.

• On February 4, 2021, The North American division of PHC Corporation partnered with Follett Products, LLC (Follett), a division of The Middleby Corporation, for the sales of the PHCbi series of ultra-low temperature (ULT) freezers, pharmaceutical-grade refrigerators and biological freezers. Both the company's healthcare clients are expected to benefit from this partnership.

B Medical Systems

Overview: B Medical Systems manufactures and distributes innovative solutions required to transport and store blood components, vaccines, laboratory specimens, etc. The company offers an end-to-end solution of refrigerated devices certified by the US FDA, EU MDR and WHO PQS. The company's portfolio includes laboratory refrigerators, medical-grade vaccine refrigerators, laboratory freezers, blood bank refrigerators, plasma freezers, contact shock freezers, ultra-low freezers and transport boxes. B Medical Systems offer storage and transportation products ranging from -80 °C to +4°C, which the Govt of Luxembourg is currently using for transporting COVID-19 vaccines.

Product Portfolio: VACCINE TRANSPORT BOX RCW1: The product is offered with the following specifications:

• Gross volume: 0.06 cu.ft. | 1.73 L
• Vaccine storage capacity: 0.04 cu.ft. | 1.04 L
• Certifications: WHO PQS E004/059
• Climate class: Hot zone (+43°C)
• Cold life at +43°C: 32h 06 min up to 10°C

Key Development

• On October 01, 2021, B Medical Systems completed its new factory extension spanning approximately 4500 square meters. The expansion project witnessed an investment of US$ 17.4 million (Euro 15 million), a part of which was funded by the Ministry of the Economy of Luxembourg due to the rising need for products to help combat the health crisis.

Why Purchase the Report?

• Visualize the global isothermal boxes for vaccine market segmentation by product, material and region, highlighting key commercial assets and players.
• Identify commercial opportunities in the isothermal boxes for vaccine market by analyzing trends and co-development deals.
• Excel data sheet with thousands of global isothermal boxes for vaccine market-level 4/5 segmentation points.
• PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.
• Product mapping in excel for the key product of all major market players

The global isothermal boxes for vaccine market report would provide approximately 69 market data tables,70 figures and 214 pages.

Target Audience 2022

• Service Providers/ Buyers
• Residential
• Research Laboratory
• Restaurant Business
• Energy & Utilities Companies
• Distributors

Table of Contents

1. Global Isothermal Boxes For Vaccine Market Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Global Isothermal Boxes For Vaccine Market - Market Definition and Overview

3. Global Isothermal Boxes For Vaccine Market - Executive Summary

• 3.1. Market Snippet by Product
• 3.2. Market Snippet by Material
• 3.3. Market Snippet by Region

4. Global Isothermal Boxes For Vaccine Market-Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Improving demand for economical cold chain solutions for the last-mile reach of vaccines is boosting the isothermal boxes
    • 4.1.1.2. XX
  • 4.1.2. Restraints
    • 4.1.2.1. Poor administration of the inventory network is restraining the isothermal boxes for the vaccine market
    • 4.1.2.2. XX
  • 4.1.3. Opportunity
    • 4.1.3.1. XX
  • 4.1.4. Impact Analysis

5. Global Isothermal Boxes For Vaccine Market - Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. Global Isothermal Boxes For Vaccine Market - COVID-19 Analysis

• 6.1. Analysis of COVID-19 on the Market
  • 6.1.1. Before COVID-19 Market Scenario
  • 6.1.2. Present COVID-19 Market Scenario
  • 6.1.3. After COVID-19 or Future Scenario
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. Global Isothermal Boxes For Vaccine Market - By Product

• 7.1. Introduction
  • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 7.1.2. Market Attractiveness Index, By Product
• 7.2. Short Range *
  • 7.2.1. Introduction
  • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.2.3. < 5 liters
  • 7.2.4. 5 - 15 liters
  • 7.2.5. 15 - 25 liters
• 7.3. Long Range
  • 7.3.1. 5 - 15 liters
  • 7.3.2. 15 - 25 liters

8. Global Isothermal Boxes For Vaccine Market - By Material

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 8.1.2. Market Attractiveness Index, By Material
• 8.2. Polyurethane *
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Polypropylene
• 8.4. Polyethylene
• 8.5. Polystyrene
• 8.6. Others

9. Global Isothermal Boxes For Vaccine Market - By Region

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 9.1.2. Market Attractiveness Index, By Region
• 9.2. North America
  • 9.2.1. Introduction
  • 9.2.2. Key Region-Specific Dynamics
  • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.2.5.1. U.S.
    • 9.2.5.2. Canada
    • 9.2.5.3. Mexico
• 9.3. Europe
  • 9.3.1. Introduction
  • 9.3.2. Key Region-Specific Dynamics
  • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.3.5.1. Germany
    • 9.3.5.2. UK
    • 9.3.5.3. France
    • 9.3.5.4. Italy
    • 9.3.5.5. Spain
    • 9.3.5.6. Rest of Europe
• 9.4. South America
  • 9.4.1. Introduction
  • 9.4.2. Key Region-Specific Dynamics
  • 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.4.5.1. Brazil
    • 9.4.5.2. Argentina
    • 9.4.5.3. Rest of South America
• 9.5. Asia-Pacific
  • 9.5.1. Introduction
  • 9.5.2. Key Region-Specific Dynamics
  • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
  • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 9.5.5.1. China
    • 9.5.5.2. India
    • 9.5.5.3. Japan
    • 9.5.5.4. South Korea
    • 9.5.5.5. Rest of Asia-Pacific
• 9.6. Middle East and Africa
  • 9.6.1. Introduction
  • 9.6.2. Key Region-Specific Dynamics
  • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
  • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material

10. Global Isothermal Boxes For Vaccine Market - Competitive Landscape

• 10.1. Competitive Scenario
• 10.2. Market Positioning/Share Analysis
• 10.3. Mergers and Acquisitions Analysis

11. Global Isothermal Boxes For Vaccine Market- Company Profiles

• 11.1. B Medical Systems *
  • 11.1.1. Company Overview
  • 11.1.2. End-User Portfolio and Description
  • 11.1.3. Key Highlights
  • 11.1.4. Financial Overview
• 11.2. BLOWKINGS India
• 11.3. Sonoco ThermoSafe
• 11.4. Termo-Kont MK LLC
• 11.5. AOV International LLP
• 11.6. Apex International
• 11.7. PHC Holdings Corporation
• 11.8. Tempack
• 11.9. Tecnisample SL
• 11.10. Nilkamal Material Handling

LIST NOT EXHAUSTIVE

12. Global Isothermal Boxes For Vaccine Market - Premium Insights

13. Global Isothermal Boxes For Vaccine Market - DataM

• 13.1. Appendix
• 13.2. About Us and Services
• 13.3. Contact Us